Medpace Inc. (MEDP)
Medpace Inc. (MEDP) Stock Price, Analysis & Data
| Precio de compra | 604.56 |
| Capitalización de mercado | 16.67B |
| Ingresos (TTM) | 2.78B |
| Beneficio neto (TTM) | 491.5M |
| Beta | 1.15 |
| EPS (TTM) | 17.56 |
| Ratio PER (TTM) | 34 |
| Adelante PE | 30.92 |
| P/B (TTM) | 38.41 |
| P/S (TTM) | 5.99 |
| Earnings Date | Oct 19, 2026 |
| Precio de venta | 595.52 |
| Volumen | 162,612 |
| Volumen medio (20D) | 321,519 |
| Abierto | 578.29 |
| Anterior Cerrar | 578.50 |
| Rango del día | 571.01 - 597.47 |
| Rango de 52 semanas | 373.00 - 677.90 |
| analista | n/a |
| Precio objetivo | 604.5 (1.24%) |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, c...
Desempeño financiero
En 2025, los ingresos de Medpace fueron 2.53B, un aumento de 19.97% en comparación con 2.11B del año anterior. Las ganancias fueron 451.12M, un aumento de 11.56%.
Estados financierosPronóstico del analista
Según las calificaciones de los analistas de 12, la calificación promedio de las acciones de MEDP es "null". El pronóstico del precio de las acciones a 12 meses es 604.5, que es Potencial alcista de 1.24% del último precio.
Previsiones bursátilesSorpresa de resultados
Los analistas proyectan ingresos de ... Actualizar
2 horas hace · Simply Wall St.
Medpace (MEDP) Stock May Be 9% Undervalued As Growth Expectations HoldAfter a 233.1% total return over the past five years, Medpace Holdings now trades in a zone where the Discounted Cash Flow (DCF) intrinsic value estimate points to a roughly fair price, while traditio...
15 horas hace · Simply Wall St.
Medpace Holdings (MEDP) Following Its Q2 Beat And Guidance Raise Looks Fully ValuedWhy Medpace Holdings Stock Is Back in Focus After Q2 Results Medpace Holdings (MEDP) drew fresh attention after reporting Q2 earnings that beat revenue expectations and came with a higher full year re...
